Priyangu phanta and priyangu taila uttara basti in the management of asrigdara ( dysfuctional uterine bleeding)

Not Applicable

• Conditions: Health Condition 1: N00-N99- Diseases of the genitourinary system

• Registration Number: CTRI/2022/04/042269
• Lead Sponsor: Faculty of Ayurveda Institue of Medical Sciences Banaras Hindu University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Patients willing to participate in the research work after giving well informed written

consent, Women between age group 18 to 45 years (all nulliparous and multiparous women) having

all or any signs & symptoms of Asrigdara as Excessive bleeding, Prolonged duration, Intermenstrual bleeding, Other than characteristics of menstrual blood

Exclusion Criteria

Age below 18 and above 45 years,Bleeding followed by abortion,Bleeding from the site other than the uterus,Any abnormalities detected in investigation ( routine and specific), Coagulation disorders, Patient suffering from chronic systemic diseases like uncontrolled hypertension, uncontrolled diabetes, venereal disease, Thyroid dysfunction, renal diseases, jaundice

or any disorders influencing general physical health and ultimately influencing

menses, Patient using IUCD & OCPs or injectable contraceptives & others, any history of allergy or allergy from trial, Central nervous system disorders like epilepsy, meningitis, migraine or

any other psychological, Respiratory disorders like bronchial asthma, tuberculosis, pneumonia,

pleural effusion, bronchitis, Cardiac disorders like angina, myocardial infarction, congenital

anomaly of heart, Gastrointestinal disorders like appendicitis, cholecystitis, hepatitis,

pancreatitis, cholelithiasis, diverticulitis, gastric ulcer, irritable bowel syndrome &

others,organic pelvic pathology, benign and malignant tumors(Vulval,

vaginal, rectal, cervical, uterine), PID, congenital anomalies of genital tract and

different type of infections of genital, breast carcinoma, Patient is on chemotherapy/ radiotherapy for any malignant condition of any organ.

Study & Design

• Study Type: Interventional
• Study Design: Not specified